Valuation of internal growth opportunities : the case of a biotechnology company
Year of publication: |
1998
|
---|---|
Authors: | Ottoo, Richard E. |
Published in: |
The quarterly review of economics and finance : journal of the Midwest Economics Association ; journal of the Midwest Finance Association. - Amsterdam [u.a.] : Elsevier, ISSN 1062-9769, ZDB-ID 1114217-0. - Vol. 38.1998, Special issue, p. 615-633
|
Subject: | Unternehmenswachstum | Firm growth | Optionspreistheorie | Option pricing theory | Biotechnologie-Industrie | Biotechnology industry | Wettbewerb | Competition | Industrieforschung | Industrial research | Theorie | Theory | USA | United States | Investition | Investment |
Extent: | Graph. Darst |
---|---|
Type of publication: | Article |
Type of publication (narrower categories): | Aufsatz in Zeitschrift ; Article in journal |
Language: | English |
Notes: | In: The quarterly review of economics and finance |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Option framework for the valuation of biopharmaceutical companies
Wörner, Stefan, (2001)
-
Competition and R&D financing decisions : theory and evidence from the biopharmaceutical industry
Thakor, Richard T., (2015)
-
Competition and R&D Financing : Evidence from the Biopharmaceutical Industry
Thakor, Richard T., (2018)
- More ...
-
The current account, the spot exchange rate and the demand for money
Joseph, Anthony, (2012)
-
Determinants of corporate growth opportunities of emerging firms
Garner, Jacqueline L., (2002)
-
The effect of managerial incentives to bear risk on corporate capital structure and R&D investment
Nam, Jouahn, (2003)
- More ...